Health Care · Biological Products, (No Diagnostic Substances) · Nasdaq · CIK 1434316 · FYE Dec 31 · Prices AT CLOSE 2026-08-19 (USD) Last $2.65 · Day +3.52% · Mkt cap $307M · 1Y +132.5% · Off 52W high −18.0% · Vol (1Y) 96.0% Price2023-08-21 → 2026-08-19 FATE close: $2.73 on 2023-08-21 to $2.65 on 2026-08-19. Split-adj closes · 240 of 3,238 · price returnⓘ At a glance | Short interest6.4% of sh out | | Days to cover4.6d | | 13F net flow (QoQ)+4.27% | | Top-10 13F concentration68.6% | | Next report (est.)2026-11-13 |
SI 2026-07-31 · 13F 2026-Q1ⓘ Key fundamentalsFY 2025 | Sales (TTM)$6.5M | | Earnings (TTM)-$126.0M | | ROE−51.8% | | Net margin−2051.1% | | Sales growth 3Y−59.0% |
FY ratios · TTM sales/earnings (USD)ⓘ Trailing returns | YTD+170.4% | | 1Y+132.5% | | 3Y−2.9% | | 5Y−96.9% | | 10Y−9.2% | | Since incept. (ann.)−6.9% |
Total return · from 2013-10-01ⓘ Risk | Ann. volatility (1Y)96.0% | | Ann. volatility (3Y)97.4% | | Sharpe (1Y)1.29 | | Sharpe (3Y)0.46 | | Max drawdown (1Y)−41.6% | | Max drawdown (3Y)−91.9% | | Beta (3Y vs SPY)3.95 |
Daily returns, ann.ⓘ Top institutional holders13F 2026-Q1 | Manager | Shares | Value | % sh out | QoQ |
|---|
| Redmile Group, LLC | 12.9M | $15M | 11.07% | +0.0% | | BlackRock, Inc. | 10.1M | $12M | 8.66% | −1.1% | | VANGUARD CAPITAL MANAGEMENT LLC | 4.2M | $5M | 3.61% | new | | VANGUARD PORTFOLIO MANAGEMENT LLC | 4.1M | $5M | 3.56% | new | | ACADIAN ASSET MANAGEMENT LLC | 4.1M | $5M | 3.54% | +40.5% | | TWO SIGMA INVESTMENTS, LP | 3.5M | $4M | 2.98% | +99.9% | | JOHNSON & JOHNSON | 3.4M | $4M | 2.91% | +0.0% | | AQR CAPITAL MANAGEMENT LLC | 3.0M | $4M | 2.58% | +158.3% |
Δ vs 2025-Q4ⓘ Latest reported quarterslast report 2026-08-13 | Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|
| 2026-06-30 | 2026-08-13 | −$0.25 | — | $2.1M | +9.2% | | 2026-03-31 | 2026-05-13 | −$0.26 | — | $1.3M | −20.3% | | 2025-12-31 | 2026-02-26 | — | — | $1.4M | −26.4% | | 2025-09-30 | 2025-11-13 | −$0.27 | — | $1.7M | −43.4% |
As-reported XBRL · next 2026-11-13 est.ⓘ Basis & disclosures - EOD closes · nothing imputed or averaged · absent “—”
- As-of differs by block · 13F = US long, 45+d lag, LOWER bound
- Not investment advice · no recommendation, price target or solicitation
- EDGAR + foreign registers · marketstack (licensed EOD) · spzco.com/methodology
| 
